Advances in drug delivery-based therapeutic strategies for renal fibrosis treatment

Author:

Huang Sida1,Lu Hanqi2ORCID,Chen Jin2,Jiang Chengyi1,Jiang Guanmin3,Maduraiveeran Govindhan4ORCID,Pan Ying1,Liu Jianqiang1ORCID,Deng Li-Er2

Affiliation:

1. Dongguan Key Laboratory of Drug Design and Formulation Technology, Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Guangdong Medical University, Dongguan, 523808, China

2. Department of Nephrology, Dongguan Hospital of Guangzhou University of Traditional Chinese Medicine, Dongguan, Guangdong 523000, China

3. Department of Oncology, Affiliated Dongguan Hospital, Southern Medical University (Dongguan people's hospital), 78 Wandao Road South, Dongguan, 523059 Guangdong, China

4. Materials Electrochemistry Laboratory, Department of Chemistry, SRM Institute of Science and Technology, Kattankulathur – 603 203, Chengalpattu, Tamil Nadu, India

Abstract

Renal fibrosis is the result of all chronic kidney diseases and is becoming a major global health hazard.

Funder

Department of Education of Guangdong Province

Basic and Applied Basic Research Foundation of Guangdong Province

Colleges Innovation Project of Guangdong

Natural Science Foundation of Guangdong Province

Publisher

Royal Society of Chemistry (RSC)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3